Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
All patients will be enrolled in Mozambique and Brazil. They will provide informed consent to use their cervical biopsy and/or LEEP specimens for imaging with DeepDOF prior to sending for standard of care processing and interpretation.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Kobiety w wieku 25-49 lat
- •Kobiety przechodzące biopsję szyjki macicy i/lub zabieg LEEP
- •Kobiety niebędące w ciąży, z negatywnym wynikiem testu ciążowego wykonanym maksymalnie 3 dni przed włączeniem do badania
- •Zdolne do wyrażenia świadomej zgody na uczestnictwo
✗ Disqualifies
- •Kobiety poniżej 25 lat lub powyżej 49 lat
- •Kobiety niezaplanowane do biopsji szyjki macicy lub zabiegu LEEP
- •Kobiety w ciąży
Simplified criteria — AI translation
Trial details
- Minimum age
- 25 Years
- Maximum age
- 49 Years
- Last updated (source)
- August 18, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
The University of Texas M. D. Anderson Cancer Center
Houston, United States
Trial contact
Kathleen M Schmeler, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/19/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.